Simplify Asset Management Inc. Has $11.41 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Simplify Asset Management Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 51.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,230 shares of the medical equipment provider's stock after purchasing an additional 7,892 shares during the period. Intuitive Surgical makes up approximately 0.5% of Simplify Asset Management Inc.'s investment portfolio, making the stock its 20th largest holding. Simplify Asset Management Inc.'s holdings in Intuitive Surgical were worth $11,412,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Mirador Capital Partners LP boosted its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock valued at $1,732,000 after purchasing an additional 50 shares in the last quarter. Advisors Asset Management Inc. raised its position in shares of Intuitive Surgical by 18.1% in the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider's stock worth $2,945,000 after acquiring an additional 1,129 shares in the last quarter. Consolidated Planning Corp grew its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock valued at $3,979,000 after buying an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider's stock valued at $39,622,000 after buying an additional 76,649 shares during the period. Finally, Brookstone Capital Management boosted its stake in Intuitive Surgical by 22.4% during the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider's stock valued at $5,340,000 after purchasing an additional 2,289 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on ISRG shares. Barclays lifted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an "overweight" rating in a report on Thursday, July 18th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an "overweight" rating in a research note on Friday, October 18th. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and raised their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average target price of $513.74.

Intuitive Surgical Trading Down 1.9 %

Shares of NASDAQ:ISRG traded down $10.19 on Friday, reaching $527.61. 1,447,836 shares of the company were exchanged, compared to its average volume of 1,461,285. Intuitive Surgical, Inc. has a 1-year low of $295.02 and a 1-year high of $544.38. The firm has a market cap of $187.92 billion, a price-to-earnings ratio of 85.96, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. The company has a 50-day moving average of $498.17 and a 200-day moving average of $456.22.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The trade was a 93.06 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 396 shares of the company's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,680,761.28. This represents a 6.71 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 91,178 shares of company stock valued at $45,897,071. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.